Does BUROSUMAB Cause Mobility decreased? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Mobility decreased have been filed in association with BUROSUMAB (CRYSVITA). This represents 0.9% of all adverse event reports for BUROSUMAB.
6
Reports of Mobility decreased with BUROSUMAB
0.9%
of all BUROSUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Mobility decreased From BUROSUMAB?
Of the 6 reports, 2 (33.3%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUROSUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BUROSUMAB Cause?
Product dose omission issue (124)
Pain (69)
Inappropriate schedule of product administration (64)
Arthralgia (59)
Therapy interrupted (57)
Blood phosphorus decreased (53)
Pain in extremity (50)
Restless legs syndrome (49)
Back pain (35)
Fatigue (34)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which BUROSUMAB Alternatives Have Lower Mobility decreased Risk?
BUROSUMAB vs BUROSUMAB-TWZA
BUROSUMAB vs BUSPIRONE
BUROSUMAB vs BUSULFAN
BUROSUMAB vs BUSULFEX
BUROSUMAB vs BUTALBITAL